Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Nov;32(11):1316-1321.
doi: 10.1016/j.annonc.2021.08.1993. Epub 2021 Aug 28.

Gene expression signatures for tailoring adjuvant chemotherapy of luminal breast cancer: the pathologists' perspective

R Salgado  1 , V Peg  2 , J Rüschoff  3 , A Vincent-Salomon  4 , I Castellano  5 , S Perner  6 , K Van de Vijver  7 , C M Quinn  8 , Z Varga  9
Affiliations
Free article
Editorial

Gene expression signatures for tailoring adjuvant chemotherapy of luminal breast cancer: the pathologists' perspective

R Salgado et al. Ann Oncol. 2021 Nov.
Free article
No abstract available

PubMed Disclaimer

Conflict of interest statement

Disclosure VP reports fees as consultant, participated in advisory boards or received travel grants from Sysmex, Roche, MSD, AstraZeneca, Bayer and Exact Sciences. KvdV reports consulting fees (advisory role) paid to the institution by Exact Sciences and AstraZeneca. No personal financial interests. ZV reports consulting fees (advisory role) by Exact Sciences and MSD/Merck. No personal financial interests. AVS reports a research grant from Nanostring, honoraria for lectures by Myriad, Nanostring and Travel grant: GenomicHealth/Exactscience. JR reports a consulting and Advisory role: MSD/Merck, GSK, BMS, Astra Zeneca, Daiichi Sankyo Europe, Roche, Exact Sciences. He's co-founder and CMO: Targos Molecular Pathology GmbH, CRO. RS reports non-financial support from Merck and Bristol Myers Squibb; research support from Merck, Puma Biotechnology, and Roche; and personal fees from Roche and Exact Sciences for advisory boards. CQ reports Roche and Genomic Health speaker fees. All remaining authors have declared no conflicts of interest.

Publication types